Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BNOS 2022 | Developing in vivo models for SHH-medulloblastoma

Max van Essen, University of Oxford, Oxford, UK, discusses the creation of an organoid derived from induced pluripotent stem cells (iPSCs) to study Shh (Sonic Hedgehog)-medulloblastoma, the most commonly occurring variant of brain tumors in infants. As iPSCs have the ability to differentiate into any cell type, cerebellar development can be examined, and an in vivo model to study medulloblastoma was successfully developed with the introduction of a PTCH1 mutation. This interview took place at the British Neuro-Oncology Society (BNOS) Annual Meeting 2022.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.